David E.I. Pyott
Board Member
Tarsus Pharmaceuticals, Inc. (TARS)Equibles does not estimate personal net worth.
Get an email with a short summary when Tarsus Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get TARS alertsAbout David E.I. Pyott
David E.I. Pyott is recorded as Board Member at Tarsus Pharmaceuticals, Inc. (TARS). The newest filing on record that lists David E.I. Pyott as Board Member at Tarsus Pharmaceuticals, Inc. (TARS) is dated April 28, 2026. Tarsus Pharmaceuticals, Inc. reported in an 8-K filed February 18, 2026 that David E.I. Pyott was appointed Class III director, effective February 18, 2026. Tarsus Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tarsus Pharmaceuticals, Inc. includes Bobak Azamian (CEO and Chairman), Jeffrey S. Farrow (CFO), Leonard Greenstein (CFO) and 7 others.
“On February 18, 2026, the Board of Directors (the "Board") of Tarsus Pharmaceuticals, Inc. (the "Company"), upon the recommendation of its Nominating and Corporate Governance Committee (the "Nominating Committee"), expanded the size of the Board from seven to eight directors and appointed David E.I. Pyott to the Board, effective immediately.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 28, 2026
Company network
Leadership on record at Tarsus Pharmaceuticals, Inc.
- Bobak Azamian CEO, Chairman
- Jeffrey S. Farrow CFO
- Leonard Greenstein CFO
- Seshadri Neervannan COO
- Bryan Wahl General Counsel
- Andrew Goldberg Board Member
- Bhaskar Chaudhuri Board Member
- Elizabeth Yeu-Lin, M.D. Board Member
- Katherine Goodrich Board Member
- Rosemary A. Crane Board Member